Judson, Ian
van der Graaf, Winette T.
Article History
First Online: 2 August 2016
Competing interests
: I.J. has received an honorarium from Eli Lilly for attendance at an advisory board meeting; however, the views expressed in this article are his own. I.J. has also received honoraria from Amgen, Ariad, Bayer, Clinigen, GSK, Nektar, and PharmaMar. W.T.v.d.G. has received a speakers' fee from Eli Lilly for an educational presentation on sarcoma, and has received research grants from GSK and Novartis.